Dan Chen outlines his vision for the Future of Cancer Immunotherapy at AACR17
Dr Daniel Chen in the Meet the Expert session at AACR17
At the recent annual meeting of the American Association for Cancer Research (AACR17) one of the 7am “Meet the Expert” sessions was with Dr Daniel Chen.
Chen is a medical oncologist and immunologist. He’s also Vice President, Global Head of Cancer Immunotherapy at Genentech and Roche.
He’s perhaps best known in the cancer immunotherapy field for his publication on the Cancer Immunity Cycle with fellow Genentech VP, Dr Ira Mellman. They have a new publication out on the Cancer-Immune Set Point that takes this forward. (See post: Understanding the Cancer-Immune Set Point).
At AACR17, Dr Chen kindly spoke to BSB about his vision for cancer immunotherapy. Anyone who has seen the film, “Jerry Maguire” starring Tom Cruise will remember the moment when Jerry drafts the memo on “The future of our business.”
What does the future of cancer immunotherapy look like from the perspective of a leading industry professional active in the field?
Subscribers can login to read more about Dan Chen’s vision
This content is restricted to subscribers
